instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | CYCLOSPORINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33794964 | 19,153,415 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychotic disorder'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,900 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual impairment'. | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | 1.8 G/M2 DAY ?4 TO DAY ?3; APLASIA INDUCING SALVAGE THERAPY OF FA5?BUCY CONDITIONING REGIMEN | DrugDosageText | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the dosage of drug 'CYTARABINE'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | 2 G/M2; 5 CONSECUTIVE DAYS FROM DAY ?13 TO DAY ?9; APLASIA INDUCING SALVAGE THERAPY OF FA5?BUCY C... | DrugDosageText | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | 30 MG/M2 DAILY; APLASIA INDUCING SALVAGE THERAPY OF FA5?BUCY CONDITIONING REGIMEN | DrugDosageText | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | AT DAY ?4 TO GRANULOCYTE IMPLANTATION | DrugDosageText | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | 10 MG/KG DAILY; STARTING FROM DAY +7 AND TAPERED AFTER ENGRAFTMENT | DrugDosageText | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the outcome of reaction 'Drug ineffective'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Fatal | ReactionOutcome | CC BY | 33794964 | 19,153,415 | 2021-04-01 |
What was the outcome of reaction 'Dysphagia'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,900 | 2021-04-01 |
What was the outcome of reaction 'Graft versus host disease'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Fatal | ReactionOutcome | CC BY | 33794964 | 19,153,415 | 2021-04-01 |
What was the outcome of reaction 'Headache'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,900 | 2021-04-01 |
What was the outcome of reaction 'Neurotoxicity'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the outcome of reaction 'Psychotic disorder'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the outcome of reaction 'Status epilepticus'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
What was the outcome of reaction 'Tremor'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,900 | 2021-04-01 |
What was the outcome of reaction 'Visual impairment'? | Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
BACKGROUND
To evaluate cyclosporine A (CSA)-related neurotoxicity after haploidentical hematopoietic stem cell transplantation (HID-HSCT) in children with hematopathy.
METHODS
This retrospec... | Recovered | ReactionOutcome | CC BY | 33794964 | 19,312,978 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic shock syndrome'. | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | CYTARABINE, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, IFOSFAMIDE, LEUCOVORIN, METHOTREXATE SODIUM, RITUXIMAB | DrugsGivenReaction | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the administration route of drug 'DEXAMETHASONE'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the dosage of drug 'CYTARABINE'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | 1 G/M2 INFUSION ON DAY 3 | DrugDosageText | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | INFUSION 20?25 MG/M2 ON DAY 4 | DrugDosageText | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the dosage of drug 'DOXORUBICIN'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | LIPOSOMAL DOXORUBICIN INFUSION 20?25?MG/M2 ON DAY 4. | DrugDosageText | CC BY | 33795020 | 19,143,911 | 2021-04-02 |
What was the dosage of drug 'IFOSFAMIDE'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | 1.2 G/M2 INFUSION ON DAY 2 | DrugDosageText | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | 3.5 G/M2 INFUSION WITHIN 3.5 H ON DAY 1 | DrugDosageText | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the dosage of drug 'METHOTREXATE'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | 3.5 G/M2 WITHIN 3.5 H ON DAY 1 | DrugDosageText | CC BY | 33795020 | 19,143,911 | 2021-04-02 |
What was the outcome of reaction 'Myelosuppression'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | Fatal | ReactionOutcome | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the outcome of reaction 'Neutropenic sepsis'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | Fatal | ReactionOutcome | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the outcome of reaction 'Pneumonia'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | Fatal | ReactionOutcome | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
What was the outcome of reaction 'Toxic shock syndrome'? | Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.
BACKGROUND
Secondary central nervous system lymphoma (SCNSL) is defined as lymphoma involvement within the central nervous system (CNS) that originated elsewhere, or a CNS ... | Fatal | ReactionOutcome | CC BY | 33795020 | 19,210,457 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.
BACKGROUND
Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial haemorrhage. We aimed to assess whether trane... | TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC | 33795488 | 19,174,708 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.
BACKGROUND
Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial haemorrhage. We aimed to assess whether trane... | TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC | 33795488 | 19,174,708 | 2021-06 |
What was the administration route of drug 'TRANEXAMIC ACID'? | Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.
BACKGROUND
Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial haemorrhage. We aimed to assess whether trane... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33795488 | 19,174,708 | 2021-06 |
What was the dosage of drug 'TRANEXAMIC ACID'? | Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.
BACKGROUND
Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial haemorrhage. We aimed to assess whether trane... | 1 g (grams). | DrugDosage | CC BY-NC | 33795488 | 19,174,708 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
Most chronic spontaneous urticaria (CSU) patients are female, and pregnancy can aggravate the disease activity of patients, but little is known about the efficacy and safety of omalizumab in pregnant CSU patients. We report two pregnant CSU patient... | CETIRIZINE HYDROCHLORIDE, EBASTINE, OMALIZUMAB | DrugsGivenReaction | CC BY | 33796115 | 20,039,738 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
Most chronic spontaneous urticaria (CSU) patients are female, and pregnancy can aggravate the disease activity of patients, but little is known about the efficacy and safety of omalizumab in pregnant CSU patients. We report two pregnant CSU patient... | CETIRIZINE HYDROCHLORIDE, EBASTINE, OMALIZUMAB | DrugsGivenReaction | CC BY | 33796115 | 20,039,738 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma recurrent'. | Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation.
Daratumumab is a humanized anti-CD38 IgG1 monoclonal antibody which could be used for multiple myeloma (MM). MM with plasma-cell leukemia (PCL) transformation is ... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 33796234 | 18,954,280 | 2021 |
What was the outcome of reaction 'Plasma cell myeloma recurrent'? | Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation.
Daratumumab is a humanized anti-CD38 IgG1 monoclonal antibody which could be used for multiple myeloma (MM). MM with plasma-cell leukemia (PCL) transformation is ... | Recovered | ReactionOutcome | CC BY-NC | 33796234 | 18,954,280 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia cytomegaloviral'. | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | CYCLOSPORINE, MYCOPHENOLIC ACID, PREDNISOLONE, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33796306 | 19,037,595 | 2021 |
What was the administration route of drug 'GANCICLOVIR'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33796306 | 19,081,604 | 2021 |
What was the dosage of drug 'CYCLOSPORINE'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | MAINTENANCE THERAPY | DrugDosageText | CC BY-NC | 33796306 | 19,037,595 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | DOSE REDUCED | DrugDosageText | CC BY-NC | 33796306 | 19,081,604 | 2021 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | MAINTENANCE THERAPY | DrugDosageText | CC BY-NC | 33796306 | 19,037,595 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | MAINTENANCE THERAPY | DrugDosageText | CC BY-NC | 33796306 | 19,037,595 | 2021 |
What was the outcome of reaction 'Chronic kidney disease'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | Recovered | ReactionOutcome | CC BY-NC | 33796306 | 19,081,604 | 2021 |
What was the outcome of reaction 'Pneumonia cytomegaloviral'? | Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure.
Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejecti... | Recovered | ReactionOutcome | CC BY-NC | 33796306 | 19,037,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'International normalised ratio fluctuation'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prosthetic cardiac valve stenosis'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prosthetic cardiac valve thrombosis'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33796313 | 19,359,551 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | Recovered | ReactionOutcome | CC BY-NC | 33796313 | 19,359,551 | 2021 |
What was the outcome of reaction 'Prosthetic cardiac valve stenosis'? | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | Recovered | ReactionOutcome | CC BY-NC | 33796313 | 19,359,551 | 2021 |
What was the outcome of reaction 'Prosthetic cardiac valve thrombosis'? | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | Recovered | ReactionOutcome | CC BY-NC | 33796313 | 19,359,551 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | Recovered | ReactionOutcome | CC BY-NC | 33796313 | 19,359,551 | 2021 |
What was the outcome of reaction 'Shock'? | Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.
Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an altern... | Recovered | ReactionOutcome | CC BY-NC | 33796313 | 19,359,551 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report.
Phosphate binders such as sevelamer are widely used in patients with chronic kidney disease to lower serum phosphate levels. We present a case of a 67-year-old woman with lower gastrointestinal bleeding after 9 days of using sevelamer carbon... | ASPIRIN, CALCIUM POLYSTYRENE SULFONATE, CHOLECALCIFEROL, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, PANTOPRAZOLE, PREDNISOLONE, SEVELAMER CARBONATE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33796314 | 19,131,944 | 2021 |
What was the administration route of drug 'SEVELAMER CARBONATE'? | Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report.
Phosphate binders such as sevelamer are widely used in patients with chronic kidney disease to lower serum phosphate levels. We present a case of a 67-year-old woman with lower gastrointestinal bleeding after 9 days of using sevelamer carbon... | Oral | DrugAdministrationRoute | CC BY-NC | 33796314 | 19,131,944 | 2021 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report.
Phosphate binders such as sevelamer are widely used in patients with chronic kidney disease to lower serum phosphate levels. We present a case of a 67-year-old woman with lower gastrointestinal bleeding after 9 days of using sevelamer carbon... | Recovered | ReactionOutcome | CC BY-NC | 33796314 | 19,131,944 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood prolactin decreased'. | Aripiprazole and lactation failure: The importance of shared decision making. A case report.
Bipolar disorder is a chronic and severe psychiatric illness affecting many patients during their childbearing years. Bipolar disorder is often managed with aripiprazole, a generally well tolerated second-generation antipsychot... | ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33796446 | 19,917,598 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lactation disorder'. | Aripiprazole and lactation failure: The importance of shared decision making. A case report.
Bipolar disorder is a chronic and severe psychiatric illness affecting many patients during their childbearing years. Bipolar disorder is often managed with aripiprazole, a generally well tolerated second-generation antipsychot... | ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33796446 | 19,585,946 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | Aripiprazole and lactation failure: The importance of shared decision making. A case report.
Bipolar disorder is a chronic and severe psychiatric illness affecting many patients during their childbearing years. Bipolar disorder is often managed with aripiprazole, a generally well tolerated second-generation antipsychot... | ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33796446 | 19,586,267 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Aripiprazole and lactation failure: The importance of shared decision making. A case report.
Bipolar disorder is a chronic and severe psychiatric illness affecting many patients during their childbearing years. Bipolar disorder is often managed with aripiprazole, a generally well tolerated second-generation antipsychot... | ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33796446 | 19,917,598 | 2021-04 |
What was the outcome of reaction 'Suppressed lactation'? | Aripiprazole and lactation failure: The importance of shared decision making. A case report.
Bipolar disorder is a chronic and severe psychiatric illness affecting many patients during their childbearing years. Bipolar disorder is often managed with aripiprazole, a generally well tolerated second-generation antipsychot... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33796446 | 19,146,526 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphoproliferative disorder'. | Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma.
Long-term methotrexate (MTX) treatment is known to cause MTX-associated lymphoproliferative disorder (MTX-LPD). A 58-year-old woman with psoriasis vulgaris and pityriasis rubra pilaris was treated with a combination of MTX... | METHOTREXATE, USTEKINUMAB | DrugsGivenReaction | CC BY | 33796880 | 19,246,033 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33798493 | 19,190,137 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33798493 | 19,190,138 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 33798493 | 19,190,131 | 2021-05 |
What was the administration route of drug 'LEUCOVORIN CALCIUM'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33798493 | 19,190,137 | 2021-05 |
What was the administration route of drug 'OXALIPLATIN'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33798493 | 19,190,137 | 2021-05 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | 350 MG, CYCLIC (2-H INTRAVENOUS INFUSION) | DrugDosageText | CC BY | 33798493 | 19,190,137 | 2021-05 |
What was the dosage of drug 'OXALIPLATIN'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | 85 MG/M2, CYCLIC (IN 250-500 ML OF 5% GLUCOSE; 2-H INTRAVENOUS INFUSION) | DrugDosageText | CC BY | 33798493 | 19,190,137 | 2021-05 |
What was the outcome of reaction 'Acute kidney injury'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | Fatal | ReactionOutcome | CC BY | 33798493 | 19,190,137 | 2021-05 |
What was the outcome of reaction 'Febrile neutropenia'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | Fatal | ReactionOutcome | CC BY | 33798493 | 19,190,138 | 2021-05 |
What was the outcome of reaction 'Infection'? | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is availabl... | Fatal | ReactionOutcome | CC BY | 33798493 | 19,190,131 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | LOTEPREDNOL ETABONATE, MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33799843 | 19,599,076 | 2021-03-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | BETAMETHASONE, FLUOROMETHOLONE, VORICONAZOLE | DrugsGivenReaction | CC BY | 33799843 | 20,662,366 | 2021-03-11 |
What was the administration route of drug 'BETAMETHASONE'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Topical | DrugAdministrationRoute | CC BY | 33799843 | 20,662,366 | 2021-03-11 |
What was the administration route of drug 'FLUOROMETHOLONE'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Topical | DrugAdministrationRoute | CC BY | 33799843 | 20,662,366 | 2021-03-11 |
What was the administration route of drug 'LOTEPREDNOL ETABONATE'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Topical | DrugAdministrationRoute | CC BY | 33799843 | 19,599,076 | 2021-03-11 |
What was the administration route of drug 'MOXIFLOXACIN'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Topical | DrugAdministrationRoute | CC BY | 33799843 | 19,599,076 | 2021-03-11 |
What was the administration route of drug 'VORICONAZOLE'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Topical | DrugAdministrationRoute | CC BY | 33799843 | 20,662,366 | 2021-03-11 |
What was the dosage of drug 'VORICONAZOLE'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | HOURLY | DrugDosageText | CC BY | 33799843 | 20,662,366 | 2021-03-11 |
What was the outcome of reaction 'Condition aggravated'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Recovered | ReactionOutcome | CC BY | 33799843 | 19,599,076 | 2021-03-11 |
What was the outcome of reaction 'Keratitis fungal'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Recovered | ReactionOutcome | CC BY | 33799843 | 20,662,366 | 2021-03-11 |
What was the outcome of reaction 'Rebound effect'? | Topical Corticosteroids and Fungal Keratitis: A Review of the Literature and Case Series.
The management of fungal keratitis is complex since signs and symptoms are subtle and ocular inflammation is minimal in the preliminary stages of infection. Initial misdiagnosis of the condition and consequent management of inflam... | Recovered | ReactionOutcome | CC BY | 33799843 | 20,685,691 | 2021-03-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis.
In April 2017 midostaurin was approved by the US Food and Drug Administration for the treatment of patients with aggressive systemic mastocytosis (ASM). So far, very limited real world data on its efficacy is available. Thirteen patients aged from ... | MIDOSTAURIN | DrugsGivenReaction | CC BY | 33799933 | 19,302,468 | 2021-03-07 |
What was the administration route of drug 'MIDOSTAURIN'? | Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis.
In April 2017 midostaurin was approved by the US Food and Drug Administration for the treatment of patients with aggressive systemic mastocytosis (ASM). So far, very limited real world data on its efficacy is available. Thirteen patients aged from ... | Oral | DrugAdministrationRoute | CC BY | 33799933 | 19,302,468 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adenovirus infection'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'BK virus infection'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacterial infection'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungal infection'. | The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience.
BACKGROUND
Knowledge about the impact of allogeneic hematopoietic stem cell transplantation (alloHSCT) on renal function in children is still limited.
OBJECTIVE
The aim of the study was to evalu... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, MYCOPHENOLATE MOFETIL, THIOTEPA, TREOSULFAN | DrugsGivenReaction | CC BY | 33799964 | 19,080,895 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy.
Here, we present a case of a 79-year-old female with a recalcitrant Staphylococcal epidermidis prosthetic knee infection that was successfully treated with a single dose of adjuvant int... | DECITABINE, ELTROMBOPAG | DrugsGivenReaction | CC BY | 33800146 | 19,283,826 | 2021-03-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy.
Here, we present a case of a 79-year-old female with a recalcitrant Staphylococcal epidermidis prosthetic knee infection that was successfully treated with a single dose of adjuvant int... | DAPTOMYCIN, ERTAPENEM SODIUM | DrugsGivenReaction | CC BY | 33800146 | 19,155,875 | 2021-03-08 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.